KRISTI SPRINGER: Open Payments
NPI 1306891817 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,400 in 117 payments from 34 companies in 2025. Trend: 2023 $1,805 · 2024 $2,140 · 2025 $2,400
Food & beverage: $2,400
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 11 | $249 |
| Janssen Biotech, Inc. | 12 | $229 |
| Genentech USA, Inc. | 9 | $195 |
| Regeneron Healthcare Solutions, Inc. | 8 | $164 |
| Merck Sharp & Dohme LLC | 6 | $123 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $105 |
| AstraZeneca Pharmaceuticals LP | 5 | $91 |
| ABBVIE INC. | 4 | $86 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $85 |
| Celgene Corporation | 4 | $83 |
Products named: LIBTAYO, REBLOZYL, Nubeqa, Ocrevus, CABOMETYX, KISQALI, KEYTRUDA, BRUKINSA.
Industry payments across AL — which companies pay providers there.
